Those looking for a gold play should consider Regis Resources Limited

With good cash flow, money in the bank and dividend payments to resume, Regis Resources Limited (ASX:RRL) has a bright future. 

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Mining stocks have experienced a turbulent ride over the past 18 months, with those in the gold sector no exception. Despite several gold stocks enjoying a significant bounce from their yearly lows, such as Northern Star Resources Ltd (ASX: NST) and Evolution Mining Limited (ASX: EVN), there are still opportunities. One of those opportunities is Regis Resources Limited (ASX: RRL).

Regis is an Australian-based gold production and exploration company. Its core operation is at the Duketon Gold Project in the North Eastern Goldfields of Western Australia, which consists of three main deposits in Moolart Well, Garden Well and Rosemont. Both Garden Well and Rosemont support robust mining schedules, and have long mine lives exceeding seven years and six years respectively.

The company has sought to extend the operational mine life at Moolart Well also, with the recent acquisition of the Gloster Gold Deposit. This deposit is strategically located 26 kilometres from Regis' Moolart Well processing plant, and has an historic resource estimate of 365,000 ounces.

In its most recent quarterly report, Regis announced it had $51.7 million in cash and $21.4 million in gold bullion. Cash holdings more than doubled in value over the quarter, and the cash position increased an incredible $100 million for the 12 months to June 2015. The company has also reduced its debt level to just $20 million, which is covered easily by available cash.

Regis has reduced operational costs over the past 12 months whilst increasing operating cash flow. It expects to generate operating cash flow of around $140 million in FY 2016, with expansion capital expenditure expected to be in the order of $15 million to $20 million for the same period.

At the mid-point of FY 2016 estimates, the company expects to produce 290,000 ounces at an AISC (all in sustaining cost) of $1,020 per ounce. This makes Regis one of the most competitive gold producers in the Australian market.

The company has also been prudent in managing its gold sales and hedging. Regis has hedged a total of 281,000 ounces at an average price of $1,437 per ounce. These hedges are not subject to a specific delivery schedule, meaning the company can choose to sell its gold at either the spot price, or the hedge price, depending on which is more profitable.

Regis has indicated it will resume dividends later this year, targeting a payout ratio of 60% of net profit after tax. A dividend target of between 5 cents and 7 cents a share indicates a dividend yield of between 3.4% and 4.7%, which is much higher than that presently offered by Northern Star and Evolution Mining.

The company also has an opportunity to improve the value provided by its Garden Well project. The project accounts for around 35% of production, but has a low recovery rate of just 83.9%. An increased recovery rate would lead to a decreased AISC and a further boost to profits.

Foolish takeaway

Regis Resources is a well-managed gold producer with low debt, long mine life and cash in the bank. It has a good hedging policy, expects to resume paying dividends later this year, and has the opportunity to boost profits further. If you are looking to add a gold stock to your portfolio, Regis Resources should be at the top of your list.

Motley Fool contributor Brett Bearham owns shares in Regis Resources. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »